language Türkçe
Article 2024 · 14 citations

The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties

Rad, Parisa Mansouri, Rahbarnia, Leila, Safary, Azam, ShadiDizaji, Azizeh, Maani, Zahra

Abstract

The low stability and nonspecific toxicity are the main limiting factors for the clinical applications of melittin (MLT). This study aimed to design and synthesize new analogs of MLT to increase stability, reduce toxicity, and retain their antimicrobial properties against bacterial pathogens. At first, peptide analogs were designed computationally by inducing single mutations in MLT peptides and evaluating their physicochemical properties. The stability of the analogs with the highest scores was determined by Gromacs software. In vitro assays were performed to examine the antimicrobial activity and toxicity of the selected analogs. Two peptide analogs, M1 and M2, were selected based on the SVM score in cell PPD. The M1 analog was created by replacing alanine with leucine on the 15th. The M2 analog was designed by substituting alanine with leucine and isoleucine with arginine at the 15th and 17th positions. According to the Gromacs results, the M2 peptide indicated more stability. RMSD and RMSF results showed no undesirable fluctuations during the 200 ns MD simulation. The MIC and MBC values for the M1 peptide were calculated in a range of 8-128 mu g/ml, while the M2 peptide limited the bacterial growth to 32-128 mu g/mL. Both peptides indicated less toxicity than natural MLT, based on MTT assay results. The hemolytic activity of the M1 analog was more than M2 at 16 mu g/mL concentration. M1 peptide displayed the highest selectivity index against S. aureus and A. baumannii, which were approximately 5.27-fold improvements compared to MLT. In conclusion, we introduced two analogs of MLT with low toxicity, low hemolytic activity, and higher stability, along with retaining antimicrobial properties against gram-negative and positive bacteria.

Keywords
Peptide analog MD simulation Antibacterial activity BEE VENOM ANTIBACTERIAL ANTIBIOTICS BACTERIA
WoS Categories
Biotechnology & Applied Microbiology Microbiology
Sustainable Development Goals
Citation
Journal
PROBIOTICS AND ANTIMICROBIAL PROTEINS
Year
2024
Volume
16
Issue
2
Pages
490-500
ISSN
1867-1306
eISSN
1867-1314
DOI
10.1007/s12602-023-10066-6
WoS UID
WOS:000966425100002
Open via DOI